Larvol Delta - Akari-Therapeutics-Announces-Abstract-Accepted-for-Oral-Presentation-at-the-40th-Annual-Society-for-Immunotherapy-of-Cancer-SITC-Meeting

AKTX-101 - Akari Therap

https://www.globenewswire.com/news-release/2025/10/03/3161000/0/en/Akari-Therapeutics-Announces-Abstract-Accepted-for-Oral-Presentation-at-the-40th-Annual-Society-for-Immunotherapy-of-Cancer-SITC-Meeting.html

Oct 3, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next